Oncology Systems Limited Announces Strategic Partnership with MPSi to Strengthen Radiotherapy Support Across the UK and Ireland
18th June 2026
Oncology Systems Limited (OSL), one of the UK and Ireland’s leading independent providers of radiotherapy and oncology products and services to the NHS and private hospitals, today announced a new strategic partnership with MPSi, a specialist provider of commissioning, consultancy, shielding calculation services, and medical physics expertise.
For more than two decades, MPSi has delivered expert commissioning of linear accelerators, advanced dosimetry support, and tailored medical physics consultancy to healthcare providers. Their team of certified physicists brings deep experience in radiotherapy system implementation, quality assurance, and workflow optimisation — capabilities that align closely with OSL’s mission to support cancer centres with world‑class technology and services.
“At OSL, we have always believed that outstanding technology is only part of the solution – the expertise to implement it safely and effectively is just as important,” said Alice Pavey, Director at Oncology Systems Limited. “Our partnership with MPSi allows us to offer our customers a truly end-to-end service, from equipment supply through to commissioning, quality assurance and ongoing physics support. This is a significant step forward in our mission to be the most comprehensive and trusted partner for radiotherapy departments across the UK and Ireland.”
Through this collaboration, OSL will offer MPSi’s full suite of services, including:
- Linear accelerator commissioning and beam modelling
- Shielding calculations and facility planning
- Advanced dosimetry and QA support
- Software development and workflow consultancy
- Specialist medical physics guidance for new and existing radiotherapy installations
“MPSi is thrilled to be able to join another respected independent provider, OSL, in a common mission to bring independent, comprehensive services to the region’s cancer centres. Our two teams’ complementary experience and skills will provide safer, more accurate, and more efficient cancer treatments throughout the UK and Ireland”, said Matt Daniels, Director of MPSi.
This partnership builds on OSL’s long‑standing role as a trusted supplier of radiotherapy equipment, software, and clinical support solutions to healthcare providers throughout the region. By integrating MPSi’s specialist services into its offering, OSL further strengthens its position as a comprehensive partner for radiotherapy departments seeking to enhance clinical performance and patient care.
About Oncology Systems Limited (OSL)
Oncology Systems Limited is a leading independent supplier of radiotherapy and oncology solutions to the NHS and private hospitals across the UK and Ireland. With a 26‑year track record, OSL provides advanced treatment technologies, QA tools, software platforms, and clinical support services designed to improve the safety, accuracy, and efficiency of cancer treatment.
About MPSi
MPSi provides commissioning, consultancy, shielding calculation services, and software development for radiotherapy departments. With over 20 years of medical physics expertise, MPSi supports healthcare providers with tailored solutions for linear accelerator commissioning, dosimetry, QA, and facility planning.
